IsoRay (ISR) Brain Cancer Results 'Impressive' - Maxim Group

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/21/2026

1. SPCX
2. NVDA
3. NFLX
4. ISRG
5. COF
6. SMCI
7. RTX
8. TSLA
9. GOOGL
10. S

Go back to IsoRay (ISR) Brain Cancer Results 'Impressive' - Maxim Group

IsoRay (ISR) Reports 'Striking' Results from Study of Brain Cancer Patients Treated with Cesium-131

December 1, 2014 8:27 AM EST

IsoRay Inc. (NYSE: ISR) today announced the striking results of a study of brain cancer patients treated with IsoRays Cesium-131 internal radiation (brachytherapy) cancer therapy. The findings of the study, conducted by researchers at Barrow Neurological Institute, were presented at the November 2014 annual meeting of the Society for Neuro-Oncology in Miami, Florida.

The Barrow study reported on 27 patients who had a variety of deadly brain cancers, including high grade gliomas, high grade meningiomas, and brain metastases. The patients had received an average of 2 and as many as 4 extensive earlier treatments that... More